Fund code: 6882

End investment

Annualized return

Choose a chart type (percentage or dollar)
Choose a predefined chart period
to:

Start NAV

$10.0000

End NAV

$10.4031
Choose a predefined chart period
to:

Calendar returns (%) 30-Nov-2024

YTD 2024 2023 2022 2021 2020
Fund 37.24 28.29 -26.98 21.68 24.70

Standard period returns (%) 30-Nov-2024

1 mo 3 mo 6 mo 1 yr 3 yr 5 yr Inception
Fund 5.13 7.79 13.55 40.44 8.89 14.63 14.36

Why invest in this fund?

  • A core equity holding that seeks to identify companies which the portfolio manager believes will offer sustained, above average earnings growth.
  • Managed with an emphasis on the U.S. market, with the flexibility to seek opportunities around the world
  • Focused on driving returns by aiming to invest in “best-of-breed” firms

Risk measures (%) 31-Oct-2024

Fund
Annualized standard deviation 16.64
Beta 1.03
0.89

Risk classification

  1. Low
  2. Low to medium
  3. Medium
  4. Medium to high
  5. High

This fund has a medium volatility rating

Allocation

Asset mix (%)

31-Oct-2024

Country mix (%)

31-Oct-2024

Sector mix (%)

31-Oct-2024
12 months ago Last month Current month
Information Technology 24.2 25.2 25.0
Communication Services 15.6 18.3 18.3
Financials 13.3 16.2 17.3
Health Care 15.7 13.8 12.8
Consumer Disc. 9.1 10.3 10.0
Industrials 7.0 8.2 8.3
Consumer Staples 2.2 1.9 1.8
Energy 5.8 1.5 1.3
Materials 2.1 1.3 1.3
Utilities 0.3 0.9 0.9
Real Estate - 0.1 0.1

Top ten holdings

  1. Meta Platforms
  2. Nvidia
  3. Berkshire Hathaway, Cl. A
  4. Microsoft
  5. Amazon.com
  6. Apple
  7. Eli Lilly and Company
  8. Alphabet, Cl. A
  9. Vertex Pharmaceuticals
  10. Regeneron Pharmaceuticals
Total number of holdings 357
Top ten holdings aggregate 50.9%
  1. Meta Platforms
  2. Nvidia
  3. Berkshire Hathaway, Cl. A
  4. Microsoft
  5. Amazon.com
  6. Eli Lilly and Company
  7. Alphabet, Cl. A
  8. Apple
  9. Vertex Pharmaceuticals
  10. Regeneron Pharmaceuticals
Total number of holdings 354
Top ten holdings aggregate 52.1%
  1. Meta Platforms
  2. Nvidia
  3. Berkshire Hathaway, Cl. A
  4. Microsoft
  5. Amazon.com
  6. Eli Lilly and Company
  7. Apple
  8. Alphabet, Cl. A
  9. Vertex Pharmaceuticals
  10. Regeneron Pharmaceuticals
Total number of holdings 351
Top ten holdings aggregate 48.8%
  1. Meta Platforms
  2. Berkshire Hathaway, Cl. A
  3. Microsoft
  4. Apple
  5. Amazon.com
  6. Nvidia
  7. Alphabet, Cl. A
  8. Eli Lilly and Company
  9. Vertex Pharmaceuticals
  10. UnitedHealth Group
Total number of holdings 325
Top ten holdings aggregate 48.3%
View all